Home
HelpTest Code DTComp Drug Test Urine Comprehensive w/o Preliminary
Useful For
Detection of a wide variety of drugs in urine.
Patient Preparation
No special patient preparation required
Collection Method
Random urine
Minimum Volume
5 mL
Container
Sterile Cup
Preferred Specimen
30 mL freshly voided urine
Acceptable Specimens
5 mL freshly voided urine
Reference or Target Ranges
| Cutoff Levels Comprehensive Drug Screen Panel * EIA comprehensive screen performed on Olympus AU680 |
|
|---|---|
| Drug | Screening Cutoff |
| 6-Acetylmorphine | 10 ng/mL |
| Acetaminophen | 25 ng/mL |
| Barbiturates | 300 ng/mL |
| Benzodiazepines | 300 ng/mL |
| Buprenorphine | 5 ng/mL |
| Cannabinoids (THC) | 50 ng/mL |
| Cocaine | 150 ng/mL |
| Ethanol | 20 mg/dL |
| Fentanyl | 10 ng/mL |
| Opiates | 300 ng/mL |
| Oxycodone | 100 ng/mL |
| Phencyclidine (PCP) | 25 ng/mL |
| Salicylate | 5 ng/mL |
| Drug Test Urine Comprehensive Limit of Quantitation (LOQ) * Drugs included in comprehensive drug test performed by GCMS analysis |
|
| Drug | LOQ |
| Amphetamine | 125 ng/mL |
| Alprazolam | 20 ng/mL |
| Butalbital | 100 ng/mL |
| Buprenorphine | 50 ng/mL |
| Carisoprodol | 100 ng/mL |
| Cocaine | 20 ng/mL |
| Codeine | 60 ng/mL |
| Clonazepam | 20 ng/mL |
| Fentanyl | 10 ng/mL |
| Hydrocodone | 60 ng/mL |
| Hydromorphone | 60 ng/mL |
| Methamphetamine | 125 ng/mL |
| Meperidine | 100 ng/mL |
| Methadone/EDDP | 100 ng/mL |
| Morphine | 60 ng/mL |
| Nordiazepam | 20 ng/mL |
| Oxycodone | 60 ng/mL |
| Oxymorphone | 60 ng/mL |
| Oxazepam | 20 ng/mL |
| Phenobarbital | 100 ng/mL |
| Phencyclidine | 20 ng/mL |
| Temazepam | 20 ng/mL |
| Tramadol | 100 ng/mL |
The following drugs will have cutoff concentrations that vary depending upon which class members and/or metabolites are present. Some drugs are only detectable at toxic concentrations as the detection limits vary depending on the drug being identified:
6-Acetylmorphine, Acetaminophen, Amitriptyline, Aripiprazole, Bupropion, Caffeine, Carbamazepine, Chlorpheniramine, Gabapentin, Hydroxyzine, Ibuprofen, Imipramine/Desipramine, Ketamine, Lamotrigine, Levetiracetam, Lidocaine, Meprobamate/Carisoprodol, Methylphenidate, Metoprolol, Mirtazapine, Naproxen, Nicotine/Cotinine, Nortriptyline, Oxcarbazepine, Paroxetine, Phentermine, Phenytoin, Quetiapine, Quinine and/or Quinidine, Salicylate, Sertraline, Topiramate, Valproic Acid, Venlafaxine
Reportable Units
ng/mL
Critical Value
Not defined for this assay
Reasons for Rejection
<!-- Rejection-->
| Hemolysis Threshold | N/A |
| Icterus Threshold | N/A |
| Lipemia Threshold | N/A |
| Other | QNS, contaminated, improperly labeled, improper specimen type |
Specimen Stability
<!-- Stability -->
| Ambient | 7 days |
| Refrigerated (4°C to 8°C) | 14 days |
| Frozen(-40°C to 0°C) | 365 days |
Performance Information
<!-- Performance information -->
| Days and Time Performed | Monday – Friday 730 AM – 430 PM |
| Expected Turn Around Time | 24 – 48 hours |
| Stat Availability | No |
| Performing Bench | Toxicology |
| Methodology/Method Description | Screen: Olympus AU680 EIA Confirmation: Liquid/Liquid extraction, Solid phase extraction, Gas chromatography mass spectrometry |
Additional Information/Important Notes
Patients that fall below the cutoff will be reported as negative.
CPT Codes
80307, G0483
Panel Components
See listing under reference ranges